Elevation Oncology【ELEV】銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.3795

買値

0.37

売値

0.39

出来高

86,714

0.375 日の範囲 0.39

0.221 52 週間の範囲 4.49

時価総額

22.472M

前日終値

0.386

始値

0.39

時刻

309

0.3795

最終取引時間

22:33:33

財務取引量

US$ 33,642

VWAP

0.387962

平均取引量 (3 か月)

1,573,862

発行済株式数

59,215,795

配当利回り

PER

-0.51

1 株当たり利益 (EPS)

-0.77

歳入

純利益

-45.7M

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be th... Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition. 詳細を表示

セクター

Biological Pds,ex Diagnstics

業界

Biological Pds,ex Diagnstics

ウェブサイト

www.elevationoncology.com

本社

Camden, Delaware, USA

設立

Elevation Oncology Inc is listed in the Biological Pds,ex Diagnstics sector of the ナスダック市場 with ticker ELEV. The last closing price for Elevation Oncology was US$0.39. Over the last year, Elevation Oncology shares have traded in a share price range of US$ 0.221 to US$ 4.49.

Elevation Oncology currently has 59,215,795 shares in issue. The market capitalisation of Elevation Oncology is US$22.86 million. Elevation Oncology has a price to earnings ratio (PE ratio) of -0.51.

Form 8-K - Current report

Elevation Oncology to Present Preclinical Data for EO-1022 at the American Association for Cancer Research (AACR) Annual Meeting 2025

Elevation Oncology to Present Preclinical Data for EO-1022 at the American Association for Cancer Research...

Form 8-K - Current report

Elevation Oncology to Discontinue Development of EO-3021; Advancing EO-1022, While Evaluating Strategic Options

Elevation Oncology to Discontinue Development of EO-3021; Advancing EO-1022, While Evaluating Strategic...

Form 8-K - Current report

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 8-K - Current report

Elevation Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Achievements

Elevation Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business...

Elevation Oncology to Participate in Upcoming Investor Conferences

Elevation Oncology to Participate in Upcoming Investor Conferences PR Newswire BOSTON, Feb. 25, 2025 BOSTON...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.1063	38.9092240117	0.2732	0.39	0.2682	1919813	0.34496436	CS
4	0.0869	29.6992481203	0.2926	0.39	0.221	1539914	0.28643762	CS
12	-0.27	-41.5704387991	0.6495	0.7394	0.221	1573862	0.41877142	CS
26	-0.2127	-35.9169199595	0.5922	0.98	0.221	1725372	0.57440545	CS
52	-3.4205	-90.0131578947	3.8	4.49	0.221	1319646	0.98841275	CS
156	-2.1205	-84.82	2.5	5.89	0.221	1016518	2.08330079	CS
260	-13.6205	-97.2892857143	14	16.22	0.221	811093	2.18057089	CS

ELEV - Frequently Asked Questions (FAQ)

What is the current Elevation Oncology share price?

The current share price of Elevation Oncology is US$ 0.3795

How many Elevation Oncology shares are in issue?

Elevation Oncology has 59,215,795 shares in issue

What is the market cap of Elevation Oncology?

The market capitalisation of Elevation Oncology is USD 22.86M

What is the 1 year trading range for Elevation Oncology share price?

Elevation Oncology has traded in the range of US$ 0.221 to US$ 4.49 during the past year

What is the PE ratio of Elevation Oncology?

The price to earnings ratio of Elevation Oncology is -0.51

What is the reporting currency for Elevation Oncology?

Elevation Oncology reports financial results in USD

What is the latest annual profit for Elevation Oncology?

The latest annual profit of Elevation Oncology is USD -45.7M

What is the registered address of Elevation Oncology?

The registered address for Elevation Oncology is 2140 S DUPONT HWY, KENT, CAMDEN, DELAWARE, 19934

What is the Elevation Oncology website address?

The website address for Elevation Oncology is www.elevationoncology.com

Which industry sector does Elevation Oncology operate in?

Elevation Oncology operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 70.70 (0.00%)	0
AADIAadi Bioscience Inc	US$ 2.05 (0.00%)	0
AACGATA Creativity Global	US$ 0.9499 (0.00%)	4
AACBUArtius II Acquisition Inc	US$ 10.0754 (0.00%)	0
AACBArtius II Acquisition Inc	US$ 9.90 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 70.70 (0.00%)	0
AADIAadi Bioscience Inc	US$ 2.05 (0.00%)	0
AACGATA Creativity Global	US$ 0.9499 (0.00%)	4
AACBUArtius II Acquisition Inc	US$ 10.0754 (0.00%)	0
AACBArtius II Acquisition Inc	US$ 9.90 (0.00%)	0
DMNDamon Inc	US$ 0.0034 (0.00%)	108.3M
STSSSharps Technology Inc	US$ 0.032 (0.00%)	61.5M
DGLYDigital Ally Inc	US$ 0.0251 (0.00%)	44.89M
RSLSReShape Lifesciences Inc	US$ 0.3097 (0.00%)	33.96M
UPXIUpexi Inc	US$ 2.295 (0.00%)	30.92M